MetaCap

Praxis Precision Medicines (PRAX) vs Dr. Reddy's Laboratories (RDY)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Praxis Precision Medicines (PRAX) has outperformed Dr. Reddy's Laboratories (RDY) over the past year, gaining 76.9% versus a gain of 7.0%. Over five years, PRAX leads with a +19.5% price change compared with +18.2% for RDY. Dr. Reddy's Laboratories is the larger company by market cap ($12.41 billion vs $8.40 billion), about 1.5 times the size.

Dr. Reddy's Laboratories pays a dividend yielding 53.73%, while Praxis Precision Medicines does not currently pay one.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PRAX+76.93%RDY+7.05%
+135%+55%-25%
Nov 21, 20251 yearNov 20, 2026
PRAX+7.28%RDY+19.43%
+41%-31%-102%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PRAX versus RDY key metrics
MetricPRAXRDY
Share price$300.43$14.89
Market cap$8.40B$12.41B
1-day change-3.37%+0.40%
YTD return+1.93%+6.05%
1-year return+76.93%+7.05%
5-year return+19.50%+18.19%
P/E ratio (TTM)—41.36
Forward P/E—22.47
EPS (TTM)$-12.82$0.36
Dividend yield0.00%53.73%
Annual dividend$0.00$8.00
Revenue (latest FY)$0$3.81B
Revenue growth (YoY)-100.00%+13.76%
Net income (latest FY)$-303.27M$663.00M
Gross margin—58.51%
Operating margin—22.09%
Net margin—17.40%
52-week high$392.70$15.67
52-week low$167.32$11.36
Distance from 52-week high-23.50%-4.98%
Analyst consensusstrong_buybuy
Avg. price target upside+124.49%+0.20%
Average volume479.87K2.85M
Shares outstanding27.95M833.66M
Employees16827,527
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • PRAX has outperformed RDY by 69.9 percentage points over the past year.
  • Dr. Reddy's Laboratories offers a meaningfully higher dividend yield (53.73% vs 0.00%).
  • Dr. Reddy's Laboratories grew revenue faster in its latest fiscal year (+13.76% vs -100.00%).

About Praxis Precision Medicines

PRAX stock →

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States. The company's platforms include Cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and Solidus to discover and develop antisense oligonucleotide.

Health Care · Biotechnology: Pharmaceutical Preparations · 168 employees

About Dr. Reddy's Laboratories

RDY stock →

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.

Health Care · Biotechnology: Pharmaceutical Preparations · 27,527 employees

PRAX vs RDY FAQ

Which is bigger, Praxis Precision Medicines or Dr. Reddy's Laboratories?

Dr. Reddy's Laboratories (RDY) is larger, with a market capitalization of $12.41B compared with $8.40B for Praxis Precision Medicines (PRAX).

Which stock has performed better over the past year, PRAX or RDY?

PRAX returned +76.93% over the past 12 months, compared with +7.05% for RDY (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Praxis Precision Medicines or Dr. Reddy's Laboratories?

Dr. Reddy's Laboratories pays a dividend yielding 53.73%, while Praxis Precision Medicines does not currently pay a regular dividend.

Are Praxis Precision Medicines and Dr. Reddy's Laboratories in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons